Refractory anemia with severe dysplasia: Clinical significance of morphological features in refractory anemia

Leukemia

Volumn 12, Issue 4, 1998, Pages 482-485

  Matsuda, A ^a   Jinnai, I ^a   Yagasaki, F ^a   Kusumoto, S ^a   Minamihisamatsu, M ^b   Honda, S ^c   Murohashi, I ^a   Bessho, M ^a   Hirashima, K ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Micromegakaryocyte; Myelodysplasia; Myelodysplastic syndromes; Pseudo Pelger Huet anomalies; Refractory anemia; Survival

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MYELODYSPLASIA; NEUTROPHIL; PRIORITY JOURNAL; REFRACTORY ANEMIA;

EID: 0031978381     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400966     Document Type: Article

References (14)

1. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 1992; 19: 4-13.
2. Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin N Am 1992; 6: 607-617.
3. Koeffler HP. Introduction: myelodysplastic syndromes. Semin Hematol 1996; 33: 87-94.
4. Hofmann WK, Ottmann OG, Ganser A, Hoelzer D. Myelodysplastic syndromes: clinical features. Semin Hematol 1996; 33: 177-185.
5. Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 1996; 10: 20-26.
6. Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micromegakaryocytes in myelodysplastic syndrome. Br J Haematol 1986; 63: 665-669.
7. ISCN (1991). Mitelman F (ed). Guideline for Cancer Cytogenetics Nomenclature. Karger: Basel, 1991.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
10. Toyama K, Ohyashiki K, Yoshida Y, Abe T, Asano S, Hirai H, Hirashima K, Hotta T, Kuramoto A, Kuriya S, Miyazaki T, Kakishita E, Mizoguchi H, Okada M, Shirakawa S, Takaku F, Tomonaga M, Uchino H, Yasunaga K, Nomura T. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 1993; 7: 499-508.
11. Gattermann N, Aul C, Schneider W. Two types of acquired sideroblastic anemia (AISA). Br J Haematol 1990; 74: 45-52.
12. Hadnagy C, Laszlo GA. Acquired dyserythropoiesis in liver disease. Br J Haematol 1991; 78: 283.
13. Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol 1991; 95: 63-71.
14. Aul C, Gatterman N, Germing U, Runde V, Helly A, Schneider W. Risk assessment in primary myelodysplastic syndromes: validation of the Dusseldorf score. Leukemia 1994; 8: 1906-1913.